renegade.bio Announces Partnership with Metabolomic Diagnostics to Reduce Pre-eclampsia-related Infant and Maternal Death February 15, 2022 San Francisco Biotechnology Network News News Comments Off on renegade.bio Announces Partnership with Metabolomic Diagnostics to Reduce Pre-eclampsia-related Infant and Maternal Death SAN FRANCISCO--(BUSINESS WIRE)--renegade.bio announces partnership with Metabolomic Diagnostics to reduce pre-eclampsia-related infant and maternal death Click to view original post